Stay updated on Nivolumab Combo Immuno-therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.

Latest updates to the Nivolumab Combo Immuno-therapy Clinical Trial page
- Check2 days agoChange DetectedUpdated the Italian site from Padua to Padova (35128) to reflect the local naming.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This indicates a new page revision/version.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now shows Revision: v3.4.2, and the earlier funding lapse notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedAdded a general site notice about the lapse in government funding and NIH Clinical Center status, and updated the page revision to v3.4.1 while removing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedThe study page now displays a glossary option and includes new metadata fields: Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and a new Revision: v3.4.0. The older items, including Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and the previous Revision: v3.3.4, have been removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combo Immuno-therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.